A Safety and Efficacy Study of Xolair in Peanut Allergy
Status:
Terminated
Trial end date:
2006-04-01
Target enrollment:
Participant gender:
Summary
This is a 38-week, randomized, double-blind, placebo-controlled, parallel group trial of
approximately 150 patients who have a history of immediate hypersensitivity reaction to
peanut protein.